Senior insider sale
SVP, Chief Technical Officer at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$11.9K
4.83K shares
What this filing means
BENESKI BENJAMIN MACHINAS plans to sell 4.83K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $11.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0002057918-26-000004
Officer· SVP, Chief Technical Officer
Since Mar 2026
4.83K
Shares to sell
$11.9K
Approx. market value
4.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
3/13/2026
4.83KTotal acquired4.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/13/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 4.83K | — |
| Total | 4.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.83K
Market value
$11.9K
3/16/2026
Total
Units
4.83K
Value
$11.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 4.83K | $11.9K | NASDAQ | Planned |
| Total | 4.83K | $11.9K | ||